Gen Digital Overview
Valuation check: GEN's ROE is 39.65%, above the Healthcare sector average of 20.86%.
Get informed when a big investor buys or sells
+ Follow39.65%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GEN is 39.65%. That is above the Healthcare sector average of 20.86%. Investors often review this figure alongside Gen Digital's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, GEN currently prints 39.65% for ROE, while the sector average sits near 20.86%. That is roughly 90.1% above the sector mean. Large gaps often invite a closer look at Gen Digital's growth, margins, and balance sheet.
Return on Equity shows how effectively Gen Digital converts resources into returns. At 39.65%, GEN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GEN's ROE (39.65%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Gen Digital's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
